Zymeworks Inc.
Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases.
264 employees · est. 2003 · Canada
Xencor is the older company (1997 vs 2003).
Side-by-Side Comparison
| Metric | Xencor | Zymeworks Inc. |
|---|---|---|
| Founded | ||
| Founded | 1997 older | 2003 |
| Headquarters | ||
| Headquarters | Pasadena, United States | Canada |
| Employees | ||
| Employees | 303 | 264 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $482.60M | $867.80M |
| Funding Rounds | ||
| Funding Rounds | 11 | 17 |
| Services | ||
| Services | Design and development of bispecific antibody drugs, Strategic collaborations with pharmaceutical companies, Extensive clinical and preclinical drug pipeline, Customization of antibodies using XmAb protein engineering platform | Development of novel medicines, Antibody drug creation, Pipeline management, Partnership and collaboration in drug development |
| Target Customers | ||
| Target Customers | Pharmaceutical companies interested in drug development partnerships, Investors seeking opportunities in biotechnology and life sciences, Healthcare professionals focused on cancer and serious disease therapeutics, Scientific research communities involved in antibody and protein engineering | Patients with difficult-to-treat diseases, Healthcare providers, Pharmaceutical companies, Biotechnology partners |
| Taxonomy | ||
| Taxonomy | Protein Engineering, Antibody Therapeutics, Biotherapeutics, Autoimmune Disease Treatment, Oncology, Asthma Treatment, B Cell Malignancies, Hodgkin's Lymphoma, Myeloma Treatment, Biosuperiors, Monoclonal Antibodies, Bispecific Antibodies, Drug Development, Cytokines, Neuroinflammatory Diseases | Antibody Therapeutics, Cancer Treatment, Autoimmune Diseases, Inflammatory Diseases, Protein Engineering, Antibody-drug Conjugates, Bispecific Antibodies, Multispecific Antibodies, Computational Biotechnology, Molecular Modeling, High-performance Computing, Protein Optimization, R&D Partnerships, Biologics Drug Discovery |
| Website | ||
| Website | xencor.com | zymeworks.com |
About Xencor
Xencor, founded in 1997, is at the forefront of the biotechnology sector, revolutionizing treatments for autoimmune diseases, asthma, and cancer through cutting-edge biotherapeutics. Their slogan, "Proteins by Design", encapsulates their innovative approach towards protein engineering. Leveraging t...
About Zymeworks Inc.
Zymeworks Inc. is a seasoned player in the biotechnology and health and wellness industries, founded in 2003 and headquartered in Canada. The company is committed to innovating medicine development for hard-to-treat cancers and serious diseases, as reflected in their slogan: "Developing novel medici...
We will tell you when either one moves
BounceWatch watches Xencor and Zymeworks Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Xencor and Zymeworks Inc. — by email.
Frequently Asked Questions
Compare Xencor with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Xencor on 9 Jun 2026, and Zymeworks Inc. on 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.